Organisation paid for research Program year 2025 Source: CMS Open Payments

Ellipsis Research Group LLC

Neither a doctor nor a teaching hospital

Research payments

$753,428

174 payments

Through program year 2025, Ellipsis Research Group LLC is reported as receiving $753,428 in research payments, across 174 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$375,143	84
2024	Research	$110,034	12
2023	Research	$141,642	4
2022	Research	$12,257	10
2021	Research	$8,408	10
2020	Research	$66,491	28
2019	Research	$39,452	26

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $373,165 82 payments
Exact Sciences Corporation $239,604 14 payments
Pfizer Inc. $77,403 36 payments
AbbVie, Inc. $39,456 36 payments
F. Hoffmann-La Roche AG $12,350 3 payments
Gilead Sciences, Inc. $10,450 2 payments
Sanofi-Aventis U.S. LLC $1,000 1 payment

Studies the money was for Research payments · program years 2019–2025

CT-388-104 OW/OB with T2D $356,265 79 payments
Informed Choice Intervention for Colorectal Cancer Screening - COMPASS $139,942 3 payments
Informed Choice Intervention for Colorectal Cancer Screening $93,134 9 payments
A Phase 3 Randomized Doubleblind Placebocontrolled 26Week Multicenter Study With A 78Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Mo $77,403 36 payments
M16-100 $18,990 16 payments
UC P3: Double-Blind Induction $16,900 3 payments
CD P3: Double-Blind Induction $12,350 3 payments
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men $11,623 8 payments
Phase 2, Blinded, Randomized, Placebo-Controlled Studies Evaluating the Safety and Efficacy of GS-4875 in Subjects with Moderately to Severely Active Ulcerative Colitis $8,550 1 payment
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS $6,528 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.